$558 Million is the total value of Iron Triangle Partners LP's 26 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 70.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ICLR | Buy | ICON PLC | $43,706,250 | +183.8% | 225,000 | +168.5% | 7.84% | +191.1% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $43,580,000 | +9.6% | 200,000 | -1.0% | 7.81% | +12.4% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $42,267,000 | – | 300,000 | +100.0% | 7.58% | – |
| COO | New | COOPER COS INC | $40,672,410 | – | 123,000 | +100.0% | 7.29% | – |
| SGRY | Buy | SURGERY PARTNERS INC | $35,660,800 | +177.1% | 1,280,000 | +132.7% | 6.39% | +184.2% |
| GILD | New | GILEAD SCIENCES INC | $32,070,899 | – | 373,569 | +100.0% | 5.75% | – |
| SNY | Sell | SANOFIsponsored adr | $31,479,500 | -8.0% | 650,000 | -27.8% | 5.64% | -5.7% |
| RGEN | Buy | REPLIGEN CORP | $30,137,180 | +61.1% | 178,000 | +78.0% | 5.40% | +65.2% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $27,762,000 | +2.4% | 600,000 | -14.3% | 4.98% | +5.0% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $26,724,408 | +51.8% | 407,074 | +26.3% | 4.79% | +55.7% |
| INSP | Sell | INSPIRE MED SYS INC | $20,150,400 | +13.6% | 80,000 | -20.0% | 3.61% | +16.5% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $19,904,570 | – | 71,576 | +100.0% | 3.57% | – |
| CI | Sell | CIGNA CORP NEW | $19,880,400 | -49.9% | 60,000 | -58.0% | 3.56% | -48.6% |
| ISRG | New | INTUITIVE SURGICAL INC | $18,574,500 | – | 70,000 | +100.0% | 3.33% | – |
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $16,464,000 | -39.8% | 200,000 | -42.9% | 2.95% | -38.3% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $13,962,115 | -15.8% | 107,749 | -28.2% | 2.50% | -13.7% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $13,906,000 | -20.1% | 1,700,000 | -43.3% | 2.49% | -18.1% |
| DXCM | Sell | DEXCOM INC | $13,597,859 | +12.6% | 120,080 | -19.9% | 2.44% | +15.4% |
| NARI | Sell | INARI MED INC | $12,076,400 | -44.6% | 190,000 | -36.7% | 2.16% | -43.2% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $11,954,630 | -68.3% | 100,089 | -71.9% | 2.14% | -67.5% |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $9,423,982 | – | 370,294 | +100.0% | 1.69% | – |
| New | AMYLYX PHARMACEUTICALS INC | $8,876,868 | – | 240,240 | +100.0% | 1.59% | – | |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $8,250,000 | – | 75,000 | +100.0% | 1.48% | – |
| MASS | Sell | 908 DEVICES INC | $6,665,450 | -55.0% | 874,731 | -2.8% | 1.20% | -53.8% |
| KPTI | New | KARYOPHARM THERAPEUTICS INC | $6,551,059 | – | 1,926,782 | +100.0% | 1.18% | – |
| STXS | Sell | STEREOTAXIS INC | $3,459,196 | +13.3% | 1,671,109 | -1.5% | 0.62% | +16.1% |
| OHPAU | Exit | ORION ACQUISITION CORPunit 02/19/2026 | $0 | – | -999,513 | -100.0% | -1.72% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -80,000 | -100.0% | -2.80% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -265,076 | -100.0% | -2.87% | – |
| HUM | Exit | HUMANA INC | $0 | – | -35,000 | -100.0% | -2.97% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -250,000 | -100.0% | -3.16% | – |
| PODD | Exit | INSULET CORP | $0 | – | -80,000 | -100.0% | -3.21% | – |
| BIO | Exit | BIO RAD LABS INCcl a | $0 | – | -50,000 | -100.0% | -3.65% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -140,000 | -100.0% | -4.50% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -487,193 | -100.0% | -4.58% | – |
| HQY | Exit | HEALTHEQUITY INC | $0 | – | -440,000 | -100.0% | -5.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.